Clinical Trial Designs

Navigating the Maze of Adaptive Design Clinical Trials

Unfavorable results during the clinical phase studies will put a damper on the drug’s journey to market. Traditionally, pharmaceutical manufacturers should have a clear hypothesis and realistic endpoints of the trial. An adaptive design clinical trials allows more flexibility in clinical studies by allowing modifications to the trial. The modifications can be done after the trial…

Details
Shifting from a One Drug Paradigm

Shifting from a One Drug Paradigm

A one-size-fits-all approach to drug therapy can be rather ineffective when treating today’s diseases. Pharmaceutical companies understand treating complex diseases such as cancer or HIV will require an effective combination of drug therapies. Combination drug product development offers significant therapeutic impact. Modern pharmacology recognizes that diseases are often multifactorial, consisting of a spectrum of medical…

Details
The FDA Drug Approval Process Improved

The FDA Drug Approval Process Improved

In 2018, the FDA pledged to improve the drug approval process and the efficiency of drug development, allowing pharmaceutical development consulting firms to serve their clients more effectively. In attempt to prevent drug shortages and to increase generic drug access, the FDA is improving their drug review process. Pharmaceutical development services can be expedited due…

Details